Literature DB >> 9491886

Crystal structure of the tyrosine phosphatase SHP-2.

P Hof1, S Pluskey, S Dhe-Paganon, M J Eck, S E Shoelson.   

Abstract

The structure of the SHP-2 tyrosine phosphatase, determined at 2.0 angstroms resolution, shows how its catalytic activity is regulated by its two SH2 domains. In the absence of a tyrosine-phosphorylated binding partner, the N-terminal SH2 domain binds the phosphatase domain and directly blocks its active site. This interaction alters the structure of the N-SH2 domain, disrupting its phosphopeptide-binding cleft. Conversely, interaction of the N-SH2 domain with phosphopeptide disrupts its phosphatase recognition surface. Thus, the N-SH2 domain is a conformational switch; it either binds and inhibits the phosphatase, or it binds phosphoproteins and activates the enzyme. Recognition of bisphosphorylated ligands by the tandem SH2 domains is an integral element of this switch; the C-terminal SH2 domain contributes binding energy and specificity, but it does not have a direct role in activation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9491886     DOI: 10.1016/s0092-8674(00)80938-1

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  256 in total

1.  Activated mutants of SHP-2 preferentially induce elongation of Xenopus animal caps.

Authors:  A M O'Reilly; S Pluskey; S E Shoelson; B G Neel
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

2.  Comparative study of protein tyrosine phosphatase-epsilon isoforms: membrane localization confers specificity in cellular signalling.

Authors:  J N Andersen; A Elson; R Lammers; J Rømer; J T Clausen; K B Møller; N P Møller
Journal:  Biochem J       Date:  2001-03-15       Impact factor: 3.857

3.  Morphogenetic movements at gastrulation require the SH2 tyrosine phosphatase Shp2.

Authors:  T M Saxton; T Pawson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

4.  The tyrosine phosphatase SHP-2 is required for sustained activation of extracellular signal-regulated kinase and epithelial morphogenesis downstream from the met receptor tyrosine kinase.

Authors:  C R Maroun; M A Naujokas; M Holgado-Madruga; A J Wong; M Park
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

Review 5.  Structural and evolutionary relationships among protein tyrosine phosphatase domains.

Authors:  J N Andersen; O H Mortensen; G H Peters; P G Drake; L F Iversen; O H Olsen; P G Jansen; H S Andersen; N K Tonks; N P Møller
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

6.  Structure and mechanism of the RNA triphosphatase component of mammalian mRNA capping enzyme.

Authors:  A Changela; C K Ho; A Martins; S Shuman; A Mondragón
Journal:  EMBO J       Date:  2001-05-15       Impact factor: 11.598

7.  The structure of the inter-SH2 domain of class IA phosphoinositide 3-kinase determined by site-directed spin labeling EPR and homology modeling.

Authors:  Zheng Fu; Eliah Aronoff-Spencer; Jonathan M Backer; Gary J Gerfen
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-10       Impact factor: 11.205

Review 8.  B cell inhibitory receptors and autoimmunity.

Authors:  Nicholas R Pritchard; Kenneth G C Smith
Journal:  Immunology       Date:  2003-03       Impact factor: 7.397

9.  Leukemogenic Ptpn11 causes fatal myeloproliferative disorder via cell-autonomous effects on multiple stages of hematopoiesis.

Authors:  Gordon Chan; Demetrios Kalaitzidis; Tatiana Usenko; Jeffery L Kutok; Wentian Yang; M Golam Mohi; Benjamin G Neel
Journal:  Blood       Date:  2009-01-29       Impact factor: 22.113

10.  Molecular basis for TPR domain-mediated regulation of protein phosphatase 5.

Authors:  Jing Yang; S Mark Roe; Matthew J Cliff; Mark A Williams; John E Ladbury; Patricia T W Cohen; David Barford
Journal:  EMBO J       Date:  2004-12-02       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.